Cabaletta Bio Appoints Steve Gavel as Chief Commercial Officer to Lead Global Launch Strategy for Rese-Cell Therapy
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced the appointment of Steve Gavel as Chief Commercial Officer, effective immediately. Gavel will oversee all aspects of commercial strategy and execution …
Cabaletta Bio Appoints Steve Gavel as Chief Commercial Officer to Lead Global Launch Strategy for Rese-Cell Therapy Read More